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Abstract 
   This study was made to evaluate the immune response to polio virus vaccine among 
PEM children by measuring the level of circulating Immunoglobulin G (IgG) antibodies 
against polio virus (IgG-PV) after immunization with the primary series of POV, and 
determining the coverage rate of universal childhood vaccine for polio virus. A cross-
sectional laboratory study was conducted in Department of Medical Microbiology and 
Clinical Immunology, Faculty of Medicine and Health Sciences, and Al-Sabeen 
University Hospital, Sana’a University. A total of 279 PEM children were selected and 
investigated for universal childhood vaccination coverage rate for polio vaccine. Blood 
samples were collected from all, then tested for levels of IgG-PV by ELISA method. For 
assessment IgG-PV levels more than 10 units/ml were considered protected against polio 
virus infection.  
  The coverage rate of polio virus vaccine for first year vaccine was 96.8%; and 91.1% of 
vaccinated PEM children responded to the vaccine with mean level of 46.2 U/ml. A 
statistically significant difference was observed with respect to sero-protective IgG-PV 
between males and females (85.7% and 94.1% respectively, p=0.002); and older children 
(>37 months) (97.7%).  
   We conclude that a small proportion of malnourished vaccinated children with a normal 
immune status were not serologically immune to polio virus infection, and remain to be 
reconsidered for either revaccination or booster doses due to lack of or inadequate 
response. PEM group gave slightly reduced response to OPV hence there is need to give 
this group IPV (injectable polio vaccine) along with OPV and different micro-nutrition 
deficiencies like Zinc and iron.  
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Introduction 
 Globally Malnutrition is the most important cause for failure of all vaccination.
1,2
 
Consistent with Independent Monitoring Board of the Global Polio Eradication Initiative, 
Tenth Report 2014 on 28th of October 2014, globally 257 polio cases were reported in 
three polio endemic countries, of which 220, wild polio cases were reported from 
Pakistan.
2,3,4
  About 165 million children are universally, chronically malnourished. This 
preventable state has affected one in every four children. Malnutrition cause 2.3 million 
children deaths per year, an average of one death per every 15 seconds.
5
 According to 
WHO majority of expected malnourished children live in developing countries. Less than 
30% of them are under the age of five years and half of them are suffering from 
PEM.
1,2
The report of MHP Yemen, and UNICEF shows the PEM is very high in Yemen 
among children (50%) this Malnutrition might be one of  the main difficulty for polio 
eradication among under five years old children in Yemen.
6
 In its 41
st
 meeting in 1988, 
World Health Assembly approved a declaration according to which “OPV is exclusively 
used worldwide for polio eradication for some reasons. It is cheaper than Intramuscular 
polio Vaccine (IPV) and can be easily orally administered”. 2 However, worldwide, the 
  
oral vaccine doesn’t effectively develop immunity against polio, particularly in 
malnourished children.
7
 Some data from WHO has also highlighted that malnutrition 
hinders the battle against polio because OPV produces four times less immunity in 
malnourished children as compared to well-nourished. Since 50% of under-five children 
are malnourished in Yemen, it is very difficult to eradicate polio from Yemen.
6
 
Therefore, our priority should be focused on preventing malnutrition in this group of 
population.  
  This study was made to evaluate the immune response to polio virus vaccine among 
PEM children by measuring the level of circulating Immunoglobulin G (IgG) antibodies 
against polio virus (IgG-PV) after immunization with the primary series of POV, and 
determining the coverage rate of universal childhood vaccine for polio virus.  
Subjects and Methods 
Ethical Consideration 
Ethical clearance for the study was taken from the Faculty of Medicine and Health 
Sciences Research Review Committee. A written permission was also taken from the 
head of the pediatric department of the Al-Sabian Hospital, Sana'a city, Yemen. Informed 
Consent was taken from the parents and guardians of all selected children before the 
questionnaire was filled in and before the blood samples were collected. 
Survey procedure and Laboratory Analysis 
Demographic data and other relevant information of each participant were obtained 
through a questionnaire. Then, about 4 ml of blood was aseptically drawn by 
venipuncture after swabbing the area of interest for sample collection with alcohol. The 
serum was then separated from the blood by allowing clotting and centrifuging. Finally, 
the serum samples were labeled and stored at -20ºC until processed. The polio IgG 
antibody ELISA test kit, manufactured and described by DEMEDITEC Diagnostic 
GmbH Germany, was used for the detection of specific IgG antibodies against polio in 
the serum of children with strict adherence to the manufacturer’s instruction manual. 
Study setting 
The study was conducted at the pediatric department of the Al-Sabian Hospital, Sana'a 
city, Yemen. The Hospital was selected because it is the only teaching  hospitals in 
Sana'a city provides health services to malnutrition children.  
Study Population 
Children between the age of 6 months to 59 months who attended the pediatric patient 
Department (PD) with PEM. These subjects of the study were take on from 17th of 
March, 2017 to 17th of September 2017 as the study population. It was ensured that they 
must have received first year oral polio vaccine doses and fulfill the eligibility criteria of 
study. A total of 279 blood samples were collected. 
Sample size 
The sample size was calculated by using sample size determination in health studies by 
WHO with 95% confidence interval and 5% level of significance with acceptable margin 
of error equal to 6% with PEM population in Yemen at least equal to 500 000 children . 
The proportions of antibodies production among malnourished subjects (“Evaluation of 
the response to vaccination against poliomyelitis and measles in malnourished children
8
 
  
was 59.5% in malnutrition children. The sample size was calculated to be 257 subjects . 
In such a small sample size, the chance of type 1 and type 2 errors are increased. To 
reduce these errors in the study, we increased the sample size to 279 subjects. 
Result 
The study included 270 malnourished children (126 males and 153 females). Most of our 
children patients were in age group 13-24 months in which they count 36.9%, followed 
by age group 3-12 months, in which the rate was 31.2% (table 1). 
The non-protective of polio-antibodies IgG rate in our children patients  was 8.6%, 
while the protective rate of polio-antibodies IgG in them was 91.4% (table 2). There was 
8.6% of malnourished children had 2-9.9IU/ml Polio-virus IgG antibodies (susceptibility 
to polio infection), 28.3% of them had 11-30IU/ml (deprived protective level, and need 
urgent booster vaccine),  42.7% of malnourished children had 31-50IU/ml (needy 
protective level which might faint in short time, and need  booster vaccine), 10.4% of 
malnourished children had 51-70IU/ml Polio-virus IgG antibodies (good health protective 
level) and  10% of malnourished children had ≥ 71 IU/ml polio-virus IgG antibodies 
(fabulous protective level) (table 3). The susceptibility rate to polio virus infection among 
males was 14.3%, higher than that of females 3.9%, with OR of susceptibility to 
poliovirus for male equal to 4.1 times than female (p=0.002). As regard to the age, the 
susceptibility rates were increase in younger age groups (table 4). Table 5 shows the 
associated odds ratio of susceptibility to polio virus infection with history of polio 
vaccine of malnourished children. There was high susceptibility rate to polio infection  
with children delivery in hospital (9.1%), and history of first month illness (9.5%), and in 
children had mixed feeding (33.3%), but no statistical significance was observed (table 
6).  
Discussion 
Yemen introduced universal immunization against Polio virus infection for infants (POV) 
in early 70s of the last century, but feedback on the coverage rate of vaccinations and 
their efficacy in the community have been ignored for a long period. In addition, 
information on the prevalence and risk determinants of polio virus infection and on 
vaccination coverage rate and immune status against polio virus infection among children 
particularly malnourished children in Yemen has been inadequate or non-existent. 
Consequently, this study has been carried out to help our understanding of some of these 
questions. In addition, seroprevalence studies provide important data on act of 
immunization programs, susceptible groups and populations at-risk of future outbreaks. 
Identifying risk factors that affect seroconversion of the oral polio vaccine (OPV) will 
enable the polio eradication initiatives to increase seroprevalence. This study 
demonstrates the first hospital-based study aiming to determine the immune status of 
malnourished children in Sana'a city against polio virus. A total of 279 serum samples 
from malnourished children in Sana'a city were collected and analyzed in this study for 
polio-specific IgG antibodies, there was 91.4% of children had protective of polio-
antibodies IgG against polio virus infection, while 8.6% of tested children had non 
protective level of polio-antibodies IgG against polio virus infection, with other words 
they are susceptible and under risk of polio virus infections.  The high seroprevalence of 
91.1% recorded in this study among malnourished children in Sana'a city indicates 
children have effectively responded to the vaccine being used in the ongoing polio 
eradication initiative in spite of malnourished. These findings are similar with United 
States study in which it was reported that 90% of healthy school age children, adolescent 
  
and young adults had detectable antibodies to Poliovirus in spite of their nourished.
9
 
However, present seroprevalence of 91.1% is higher than the findings of Egypt by El-
Sayed et al.
10
, (37.8%) and Morocco  by Yousuf et al.
8
 (21.4%), among malnourished 
children groups.  
    The current  study seroprevalence of protective IgG antibodies for polio virus  was 
slightly higher (94.1%) in females compared to males (85.7%), this result is different 
from study  by Iliyasu et al.
11
 in Nigeria, but similar to Donbraye et al.
12
 study in Nigeria 
where females had higher antibody titers for all the three serotypes.  Also our result is 
similar to Baba et al.
13
 in India and to Chinese study by Wang et al.
14
 also. Sex 
differential non-specific effects of vaccines are common in developing countries with 
negative non-specific effects (NSE) of inactivated vaccines more common in girls than 
boys 
16,17 
in some countries, but with no differences in high income countries.
17 
Though 
the general pattern is both negative and positive NSE are stronger in females
18
 , a 
randomized controlled trial in Guinea-Bissau negated the hypothesis that mortality rates 
in boys would be lower if they had not received OPV.
19
 The reasons why OPV uptake is 
slightly higher for females in our study area are unknown. Though factors such as age, 
gender and urban setting have no remedial solution from a public health perspective, this 
study indicates that response may be affected by factors that are not amenable to 
modification. This is important for the understanding of oral vaccine performance in low-
income countries.  When we considered age groups, there was trend toward increased rate 
of positive protective levels of IgG antibodies against polio virus in the current study in 
which the higher seropositivity rate was in the older age group ( ≥ 37 months age group) 
(97.7%) and the lowest protective rate was 87.4% in 6-12 months age group (table 4). 
This similar to findings in previous studies in Vellore district of Tamil Nadu - Sri Lanka  
in which lower rate of protective antibodies rate was found in children under one years of 
age.
20
 This could be due to a more mature immune system or to receipt of OPV doses that 
are not recorded in the vaccination history taken for the child.  
   When we study the associated odds ratio of susceptibility to polio virus infection with 
history of polio vaccine among malnourished children in Sana'a city Yemen, there was 
increased rate of susceptibility for polio virus in our study among children whom not had 
national camping booster polio vaccine in which the rate of susceptibility was 14.6%, 
while the rate of susceptibility among children whom had national camping booster polio 
vaccine was 5.5% only (table 5). Our result is similar to previously reported studies in 
which increasing the number of OPV doses received by children, decreasing the 
susceptibility rate for polio virus; and increase the polio-seroconversion rates among 
children. 
8,11,21
  
Conclusions 
  We conclude that a small proportion of malnourished vaccinated children with a normal 
immune status were not serologically immune to polio virus infection, and remain to be 
reconsidered for either revaccination or booster doses due to lack of or inadequate 
response; more information, however, needs to be gathered first on the occurrence of 
clinical/subclinical poliomyelitis cases (morbidity and mortality) and the overall 
morbidity and mortality following polio vaccination. Also the rates of vaccine coverage 
for the routine immunization schedule of childhood vaccines were good.  
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Table 1: The age and sex distribution of malnourished children, whom tested for immune 
status against polio virus, Sana'a city, Yemen 
Age groups Male Female Total 
No %  No % No % 
6 -12 months 42 33.3 45 29.4 87 31.2 
13-24 months 48 38.1 55 35.9 103 36.9 
25-36 months 18 14.3 27 17.6 45 16.1 
≥ 37 months 18 14.3 26 17 44 15.8 
Total 126 45.2 153 54.8 279 100 
 
Table 2: The immune status of malnourished children against polio virus, Sana'a city, 
Yemen 
Immune status Number percentage P V 
Non-protective level of polio-antibodies IgG (≤9.9 
IU/ml) 
24 8.6  
 
< 0.05 Protective level of polio-antibodies IgG  
(≥ 10 IU/ml) 
255 91.4 
Total 279 100  
 
Table 3: The interpretations of the poliomyelitis virus IgG antibodies level among 
malnourished children, Sana'a city, Yemen 
Polio-virus IgG antibodies IU/ml Number Percentage Interpretations' 
2 - 9.9 IU/ml 24 8.6 Susceptible to polio infection 
11- 30. IU/ml 79 28.3 deprived protective level, need 
urgent booster vaccine 
31- 50 IU/ml 119 42.7 needy Protective level which might 
faint in short time, need  booster 
vaccine 
51 - 70 IU/ml 29 10.4 in good health protective level 
≥ 71  IU/ml 28 10 fabulous protective level 
  
Table 4: The frequency and associated odds ratio of susceptibility to polio virus infection 
with different sexes and age groups of malnourished children in Sana'a city Yemen. 
Characters Non-protective level 
N=24 
OR CI       χ 2 PV 
No % 
Sex: 
Male n=126 
 
18 
 
14.3 
 
4.1 
1.6-10.6 9.4 0.002 
Female n=153 6 3.9 0.24 0.1-0.6 9.4 0.002 
Age groups 
6-12 m n=87 
 
11 
 
12.6 
 
2 
 
0.9-4.6 
 
2.6 
 
0.1 
13-24 m n=103 9 8.7 1 0.4-2.4 0.004 0.95 
25-36 m n=45 3 6.7 0.7 0.2-2.5 0.25 0.61 
≥ 37 m n=44 1 2.3 0.21 0.02-1.6 2.66 0.102 
Total 24 8.6 - - - - 
OR          Odds ratio >1 (at risk) 
CI           Confidence intervals  
 χ 2         Chi-square ≥3.9 (significant) 
 p             Probability value ≤0.05 (significant) 
 
Table 5: The associated odds ratio of susceptibility to polio virus infection with history of 
polio vaccine of malnourished children in Sana'a city Yemen. 
Characters Non-protective level 
N=24 
OR CI       χ 2 PV 
No % 
First year vaccine 
Yes n=270 
 
24 
 
8.9 
Undefined 0.87 0.34 
No n=9 0 0 undefined 0.87 0.34 
Booster dose  
Yes n=243 
 
21 
 
8.6 
 
1.04 
 
0.29-3.6 
 
0.04 
 
0.95 
No n=36 3 8.3 0.96 0.27-3.4 0.4 0.95 
National camping booster dose 
Yes n=183 
 
10 
 
5.5 
 
0.49 
 
0.21-1.13 
 
6.8 
 
0.01 
No n=96 14 14.6 2.8 1.2-6.6 6.8 0.01 
OR          Odds ratio >1 (at risk) 
CI           Confidence intervals  
 χ 2         Chi-square ≥3.9 (significant) 
 p             Probability value ≤0.05 (significant) 
 
  
Table 6: The associated odds ratio of susceptibility to polio virus infection with site of 
delivery, history of illness during first month of life, and type of feeding of malnourished 
children in Sana'a city Yemen. 
Characters Non-protective level 
N=24 
OR CI       χ 2 PV 
No % 
Site of delivery 
Hospital n=165 
 
15 
 
9.1 
1.2 0.49-2.7 0.12 0.72 
House n=114 9 7.9 0.85 0.36-2.1 0.12 0.72 
History of first month illness 
Yes n=158 
 
15 
 
9.5 
 
1.4 
 
0.6-3 
 
0.36 
 
0.54 
No n=121 9 7.4 0.7 0.3-1.8 0.56 0.54 
Type of feeding 
Mother feeding n=195 
 
15 
 
7.7 
0.7 0.3-1.6 0.18 0.40 
Bottle feeding n=75 6 8 0.89 0.34-2.3 0.05 0.82 
Mixed n=9 3 33.3 5.9 1.4-25.4 7.2 0.007 
OR          Odds ratio >1 (at risk) 
CI           Confidence intervals  
 χ 2         Chi-square ≥3.9 (significant) 
 p             Probability value ≤0.05 (significant) 
